advanced or metastatic non-small cell lung cancer

6 total trials 1 recruiting

Filter these 6 trials by phase, country, sponsor and more.

Open in Search →

Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad … Pending

2025-521221-32-00 5
A Study of Navlimetostat (BMS986504) in Participants with Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer with Homozygous MTAP … Recruiting

2024-519814-29-00 4 2025-09-12
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer Recruitment ended

2025-521115-40-00 4 2025-09-30
Study of ceralasertib plus durvalumab versus docetaxel for patients with advanced or metastatic non-small cell lung cancer Recruitment ended

2023-509429-37-00 5 2022-10-03
Efficacy and safety of UV1 vaccination +/- standard of care as first line treatment of patients with non-small cell lung cancer Ended

2022-502437-25-00 4 2022-08-15
A Study of Valemetostat Tosylate Plus Pembrolizumab versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations Ended

2024-519671-26-00 9

Showing 1–6 of 6 trials